ApiJect awarded $138M DPA contract for syringe production

ApiJect Systems America was awarded a $138 million HHS-DOD Title 3 Defense Production Act contract to accelerate building U.S.-based capacity for prefilled syringes, including Project Jumpstart to supply 100 million syringes by end of 2020 and over 500 million in 2021.

“ApiJect Systems America, Inc., a public benefit corporation based here, today announced that it has been awarded an HHS-DOD Title 3, DPA contract valued up to $138 million to accelerate the building of a new U.S.-based, high-speed, population-scale emergency drug injection capability with prefilled ”prnewswire.com

• 1 source
• prnewswire.comApiJect Awarded HHS-DOD Title 3, Defense Production Act (DPA) Contract of $138 Million in Support of a Joint Federal Agency Accelerated Build-out of Domestic Surge Capacity for a High-Speed, Population-Scale Emergency Drug Injection SolutionApiJect Systems Corp.May 12, 2020

Summarized from public sources; check the original articles before acting on it.